Ewch i’r prif gynnwys
Dr Jennifer Swettenham

Dr Jennifer Swettenham

Trial Manager

Ysgol y Biowyddorau


I am a Clinical Trial Manager working in the Cancer Group of the Centre for Trials Research (CTR). I primarily work on the COPELIA trial which is a multi-centre, phase II trial testing two new oral treatments for endometrial cancer.

I have worked in three UKCRC registered Clinical Trial Units; previously I worked at the Oxford Clinical Trials Research Unit (OCTRU) where I was the trial manager for research investigating disorders of localised fibrosis. I mainly worked on Dupuytren’s disease—a fibrotic condition in which affected fingers irreversibly curl towards the palm. I set up and managed the RIDD trial—Repurposing antI-TNF to treat Dupuytren’s Disease—which examined the cellular changes produced by anti-TNF in human Dupuytren’s tissue, and whether anti-TNF can halt or slow the progression of Dupuytren’s disease. I also worked on developing a questionnaire-based study of Dupuytren’s disease in the community (DISCO), and a clinical trial for treating Frozen Shoulder (Anti-Freaze).

Prior to working at OCTRU, I was the Infectious Diseases Trial Co-ordinator at the Primary Care Clinical Trials Unit (University of Oxford). There I worked on drug trials that aimed to treat conditions such as sore throat (TOAST trial) and influenza (ALIC4E trial) and to reduce antibiotic use in primary care.

My background is in neuroscience and I have more than ten years’ experience of running human behavioural and neuroimaging (magnetoencephalography (MEG) and magnetic resonance imaging (MRI)) studies. As Research Facilitator at OHBA (Oxford centre for Human Brain Activity, University of Oxford), I helped researchers develop their studies, obtain regulatory approvals and trained them to operate the neuroimaging equipment. My own research was mainly on visual processing, but I worked on many studies covering a wide range of cognitive processes in both the healthy and non-typical brain.


Career overview

  • 2017-present: Clinical Trial Manager, Solid Tumours, Centre for Trials Research, Cardiff University, UK.
  • 2015-2017: Clinical Trial Manager, Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, UK.
  • 2014-2015: Clinical Trial Coordinator: Primary Care Clinical Trials Unit (PC-CTU), University of Oxford, UK.
  • 2011-2014: Research Facilitator: The Oxford Centre for Human Brain Activity (OHBA), University of Oxford, UK.
  • 2010-2011: Visiting Lecturer: Aston University, UK.
  • 2009-2011: Post-doctoral Research Associate: Studies of autism spectrum disorder (ASD), University of Oxford, UK.
  • 2006-2009: Post-doctoral Research Associate: Cardiff University Brain and Repair Imaging Centre (CUBRIC), Cardiff University, UK.
  • 2000-2001: Laboratory Manager at Weston Medical Ltd., Eye, UK.

Education and qualifications

  • 2001-2006: PhD: ‘Functional neuroimaging and behavioural studies on global form processing in the human visual system’: Aston University, UK.
  • 1996-2000: BSc (Hons) Neuroscience 1st Class at University of Nottingham, UK.
  • 1998-1999: Industrial Placement Student at Eli Lilly and Co., Windlesham, UK.

Pwyllgorau ac adolygu

  • 2017-present: Member of the Centre for Trials Research Risk Assessment Group (RAG)
  • 2017-present: Member of the Centre for Trials Research Learning and Development Group









Meysydd arbenigol